XML 62 R44.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Business Combinations (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended 6 Months Ended 1 Months Ended 6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
Dec. 31, 2010
Jun. 28, 2011
ABH Member
Jun. 30, 2011
ABH Member
Business Acquisition, Date of Acquisition              
Effective Date of Acquisition             2011-06-28
Period Results Included in Combined Entity             2011-06-28
Business Acquisition, Entity Acquired and Reason for Acquisition              
Reason for Business Combination           The acquisition of Adcanced BioHealings ("ABH") adds the DERMAGRAFT product, a regenerative bio-engineered skin substitute, to Shire’s portfolio. The acquisition combines ABH’s expertise and commercial capability in regenerative medicine with the Company’s strengths and expertise in human cell biological manufacturing.  
Percentage of Voting Interests Acquired             100.00%
Business Acquisition, Cost of Acquired Entity              
Cost of Acquired Entity, Cash Paid           $ 739.2  
Short-term debt 30.0   30.0   0    
Business Acquisition, Purchase Price Allocation, Current Assets              
Cash and Cash Equivalents           14.6  
Accounts receivables           30.1  
Inventory           31.8  
Deferred Tax Asset, Current           32.3  
Other Current Assets           7.9  
Purchase Price Allocation, Current Assets, Total           116.7  
Business Acquisition, Purchase Price Allocation, Noncurrent Assets              
Property, Plant and Equipment           16.5  
Goodwill           192.5  
DERMAGRAFT product technology           710.0  
Other Intangible Assets           1.5  
Other Noncurrent Assets           0.1  
Purchase Price Allocation, Assets Acquired, Total           1,037.3  
Business Acquisition, Purchase Price Allocation, Current Liabilities              
Accounts Payable and Other Current Liabilities           49.3  
Business Acquisition, Purchase Price Allocation, Noncurrent Liabilities              
Long term debt, less current portion           9.1  
Deferred Tax Liabilities, Noncurrent           238.7  
Other Noncurrent Liabilities           1.0  
Liabilities Assumed, Total           298.1  
Assets Acquired (Liabilities Assumed), Net, Total           739.2  
Additional Business Combination Disclosures              
Revenues 1,062.9 849.4 2,035.1 1,665.5   2.0  
Integration and Acquisition Cost 9.0 0 2.6 0.6   6.9  
Net Income (Loss) $ 205.5 $ 160.5 $ 416.8 $ 326.2   $ (0.6)